A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours

Clinical trial NCT04914117 · COMPLETED

Trial details

NCT number: NCT04914117
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unresectable Solid Tumor Metastatic Solid Tumor Locally Advanced Solid Tumor

Start date: 2021-11-29
Primary completion: 2022-11-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.